Get the full picture
Sign in to uncover key details.
Illuminare Biotechnologies
Business Services · New York, United States · 1-10 Employees
View Company Info for Free
Overview
Headquarters
325 Saint Marks Ave, Brooklyn, New York,...Website
www.illuminarebio.comRevenue
<$5 MillionIndustry
About Illuminare Biotechnologies
Illuminare Biotechnologies is a clinical stage biotechnology company dedicated to enhancing intraoperative nerve visualization to minimize the risk of nerve damage during surgeries. Their lead product, Illuminare-1, is a small molecule designed for immediate and sustained nerve illumination, which has shown safety and initial efficacy in a first-in-human trial. The company aims to improve surgical outcomes by providing surgeons with better visualization of nerves, particularly in procedures like radical prostatectomy. Illuminare Biotechnologies plans to advance to Phase 2 trials in 2026.Explore more
SIC Code 87,873NAICS Code 54,541Show moreIlluminare Biotechnologies Org Chart
Sell smarter with deeper company insights.
ZoomInfo gives you access to real-time firmographics, buying signals, org charts, and decision-makers - helping your GTM teams prioritize accounts, personalize outreach with AI-driven automation, and close deals faster.
Compare Similar Companies to Illuminare Biotechnologies
Compare insights from companies similar to Illuminare Biotechnologies, focusing on performance, financial data, growth rates, and unique benchmarks to identify key industry trends and opportunities.
Revenue
Number of Employees
Type
Funding
Founded In
Illuminare Biotechnologies Tech Stack
A closer look at the technologies used by Illuminare Biotechnologies
Top Business Services Companies
Top companies in Canada by revenue
Frequently Asked Questions Regarding Illuminare Biotechnologies
Sign Up For FreeTo access detailed company insights
Illuminare Biotechnologies is a clinical stage biotechnology company dedicated to enhancing intraoperative nerve visualization to minimize the risk of nerve damage during surgeries. Their lead product, Illuminare-1, is a small molecule designed for immediate and sustained nerve illumination, which has shown safety and initial efficacy in a first-in... Read More
